Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
On Monday, Rivian announced an expectations-beating jump in deliveries for its third quarter. But a new report says it’s still losing money.
In an interview with Bloomberg, CEO Brian Chesky laid out how Airbnb has been rocked by user dissatisfaction and tighter regulation.
Despite widespread monetary rain clouds pushing up the cost of beer and food, drinkers are showing up in record numbers to Oktoberfest.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
An intense geopolitical fight is raging at the moment, and the future of deep sea mining does hang in the balance.
There’s been this little obstacle standing in the way of a functioning nationwide marijuana market: the law.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Ethanol has been good to corn farmers. But when everybody starts switching to electric vehicles, where’s all that maize going to go?
While many agree US railroads desperately need refurbishing, some question why federal dollars should support a highly privatized industry.
McDonald’s has had a tenuous relationship with its franchise operators as of late. A new round of royalty fee hikes isn’t likely to help.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.